INS and Hyperglycemia: In addition, GSK-3 inhibitors improve insulin sensitivity in rodent models of diabetes, alleviating hyperglycaemia by decreasing hepatic gluconeogenesis and stimulating glycogen synthesis [4], [5], [6].